D
Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA · NASDAQ · Financial Services · 260M
Closing price
$10.85
+0.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
38.4×
Price / net assetsP/B
1.0×
Enterprise value / EBITDAEV/EBITDA
-80.9×
Free cash flow yieldFCF yield
-0.2%
Return on equityROE
2.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.